Holen Sie sich die Stockscreener-App
62.59
0.37%
-0.23
Handel nachbörslich:
62.52
-0.07
-0.11%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Corp. stock: Down 35% but analysts see rebound potential - AD HOC NEWS
Boston Scientific (BSX) Price Target Lowered by Evercore ISI Gro - GuruFocus
Boston Scientific closes buyout of Valencia Technologies - MedTech Dive
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Piper Sandler maintains Boston Scientific stock rating after device feedback - Investing.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are th - Benzinga
Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Why Boston Scientific's big dip could be a bigger opportunity - MSN
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp. Stock: Strong Growth in Medtech Amid Evolving Healthcare Demands - AD HOC NEWS
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific completes acquisition of California bladder treatment company - Worcester Business Journal
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) - GlobeNewswire
RBC Capital reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
RBC Capital reiterates Boston Scientific stock rating on growth outlook - Investing.com
Here are the largest manufacturers in Massachusetts - The Business Journals
Banque Pictet & Cie SA Has $25.83 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
BSX Price History for Boston Scientific Corp Stock - Barchart.com
[EFFECT] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific (NYSE: BSX) to acquire Penumbra in $374/share deal - Stock Titan
Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints - Insider Monkey
Boston Scientific (XSWX:BSX) Shiller PE Ratio : (As of Apr. 01, 2026) - GuruFocus
Nisa Investment Advisors LLC Sells 18,182 Shares of Boston Scientific Corporation $BSX - marketbeat.com
List of 57 Acquisitions by Boston Scientific (Apr 2026) - Tracxn
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast - Yahoo Finance
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
Boston Scientific presents Watchman FLX and EKOS endovascular system data - Medical Device Network
FDA clears Boston Scientific’s Asurys system for endoscopic procedures - Medical Device Network
UBS reiterates Boston Scientific stock Buy on trial success - Investing.com
Boston Scientific (BSX) Stock Plunges 9% on Watchman Trial Concerns and Rating Cut - Blockonomi
Boston Scientific (BSX) Stock Falls 9% After Watchman Trial Data and Analyst Downgrade - CoinCentral
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT) - theglobeandmail.com
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - theglobeandmail.com
Boston Scientific (BSX) Gets a Buy from Canaccord Genuity - theglobeandmail.com
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm - PR Newswire
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. - Barron's
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
AI Models Turn More Positive on Boston Scientific, But Weak Technicals Temper Enthusiasm - TipRanks
Boston Scientific (BSX) Receives a Buy from RBC Capital - theglobeandmail.com
Boston Scientific Stock Tumbles 9% Following Raymond James Downgrade - TIKR.com
Can Boston Scientific Stock Surge 40% From Here? - Yahoo Finance
Is There An Opportunity In Boston Scientific (BSX) After Steep Recent Share Price Declines? - simplywall.st
Boston Scientific Corporation $BSX Stock Holdings Cut by J. Safra Sarasin Holding AG - marketbeat.com
Boston Scientific dives after disappointing clinical trial results - medwatch.com
Raymond James downgrades Boston Scientific (BSX) - MSN
Boston Scientific Corporation $BSX Shares Purchased by Brookstone Capital Management - marketbeat.com
Allspring Global Investments Holdings LLC Raises Position in Boston Scientific Corporation $BSX - marketbeat.com
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific study backs use of intravascular ultrasound in PCI - MassDevice
Time To Buy The Dip In Boston Scientific Stock? - Trefis
Is 18.1% Fall In Boston Scientific (BSX) Stock A Buying Opportunity? - Trefis
Boston Scientific (BSX) Stock Trades Down, Here Is Why - Yahoo Finance
Boston Scientific (BSX) Downgraded by Raymond James: Target Pric - gurufocus.com
Boston Scientific (BSX) Gains Confidence with CHAMPION-AF Data - GuruFocus
Boston Scientific's (BSX) Trial Results Fall Short of Expectatio - GuruFocus
Boston Scientific (BSX) Faces FTC Second Request in Merger Revie - GuruFocus
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results - The Motley Fool
Needham Reiterates Buy Rating for BSX with Stable Price Target | - GuruFocus
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):